Back to News index
Statement of intent for UK life sciences
UK life sciences industry commitment to fighting COVID-19 and supporting NHS patients
As part of the health community, the life sciences sector in the UK wants to play as big a role as possible in tackling COVD-19 – both in the search for effective diagnostics and treatments and by supporting patients, the NHS and Government across the UK.
Our companies have the experience, knowledge and facilities to provide support across healthcare if they work together during this crisis. We are focussed on three areas:
1. Delivering medicines and health technology to fight COVID-19
- Prioritise research and development of COVID-19 related diagnostics, treatments, health technologies and vaccines.
- Facilitate input and intelligence sharing from companies to support patient testing and therapeutics.
- Identify and support companies to facilitate testing for COVID-19.
2. Prioritising the supply of diagnostics, medicines and health technologies for NHS patients
- We are prioritising getting medicines and health technologies to NHS patients, working to mitigate any impact that global supply chain, manufacturing and transport disruption may have on the availability of medicines and health technologies, including for clinical study and research activities.
3. Supporting NHS service delivery
- Identify and support the opportunities for thousands of highly skilled people working in life science - including doctors, nurses and pharmacists and non-clinical staff – to volunteer to help where most needed
- Supporting the NHS to improve capacity for COVID-19 testing and diagnostics.